HONG KONG – Apollobio Corp., of Beijing, has updated and finalized its development and commercialization deal with Inovio Pharmaceuticals Inc., of Plymouth Meeting, Pa., for a vaccine developed for pre-cancers caused by human papillomavirus (HPV).